• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 3 filed by new insider Carr Alan Jeffrey

    8/8/25 2:44:30 PM ET
    $GOCO
    Specialty Insurers
    Finance
    Get the next $GOCO alert in real time by email
    SEC FORM 3 SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    Carr Alan Jeffrey

    (Last) (First) (Middle)
    222 W MERCHANDISE MART PLAZA
    SUITE 1750

    (Street)
    CHICAGO IL 60654

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    08/06/2025
    3. Issuer Name and Ticker or Trading Symbol
    GoHealth, Inc. [ GOCO ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    Remarks:
    Exhibit 24 - Power of Attorney.
    No securities are beneficially owned.
    /s/ Bradley Burd, Attorney-in-fact 08/08/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $GOCO alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GOCO

    DatePrice TargetRatingAnalyst
    4/1/2022$1.50Underperform
    Credit Suisse
    3/3/2022$10.00 → $2.00Outperform → Sector Perform
    RBC Capital
    3/2/2022Buy → Hold
    Truist
    3/2/2022$2.00Buy → Hold
    Truist Securities
    1/7/2022$6.00 → $3.00Neutral → Underperform
    Credit Suisse
    1/5/2022$7.50 → $3.50Buy → Underperform
    B of A Securities
    11/15/2021$7.00 → $6.00Neutral
    Credit Suisse
    11/11/2021$13.00 → $5.50Equal-Weight
    Morgan Stanley
    More analyst ratings

    $GOCO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    GoHealth Announces Strategic Capital and Governance Actions to Support Long-Term Value Creation and Reports Second Quarter 2025 Results

    CHICAGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO) ("GoHealth" or the "Company"), a leading health insurance marketplace and Medicare-focused digital health company, today announced the execution of strategic capital and governance actions that are expected to significantly enhance its financial flexibility and long-term positioning along with its financial results for the three and six months ended June 30, 2025. Strategic Capital and Governance Actions Secured new senior secured superpriority term loan facility, including $80.0 million in new-money term loans and $35.0 million in roll-up loans, to support working capital and stra

    8/7/25 7:00:00 AM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth to Announce Strategic Capital and Governance Actions to Support Long-Term Value Creation and Second Quarter 2025 Results

    CHICAGO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (GoHealth) (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, will announce strategic capital and governance actions to support long-term value creation and its second quarter 2025 financial results on the morning of August 7, 2025. Chief Executive Officer, Vijay Kotte, and Chief Financial Officer, Brendan Shanahan, will host a conference call and live audio webcast on the day of the release at 8:00 a.m. (ET) to discuss recent strategic capital and governance actions. A live audio webcast of the conference call will be available via GoHealth's Investor Relations websi

    8/6/25 4:15:00 PM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth Secures Amended Credit Agreement Highlighting Broad Based Support from Stakeholders

    CHICAGO, June 30, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO), a leading health insurance marketplace, today announced it has entered into an amendment with its lenders under the Company's existing credit agreement in order to, among other things, provide covenant adjustments as well as extend the maturity of the Company's revolving credit facility through September 30, 2025. The amendment also provides consent for the Company to pursue a receivables financing (such consent also covering a securitization transaction) as the parties continue to work toward a comprehensive financing plan intended to alleviate the Company's recent going concern position, strengthen the Company's fin

    6/30/25 4:30:00 PM ET
    $GOCO
    Specialty Insurers
    Finance

    $GOCO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Kotte Vijay bought $100,275 worth of shares (7,500 units at $13.37), increasing direct ownership by 1% to 653,630 units (SEC Form 4)

    4 - GoHealth, Inc. (0001808220) (Issuer)

    11/15/23 10:10:34 AM ET
    $GOCO
    Specialty Insurers
    Finance

    $GOCO
    SEC Filings

    View All

    $GOCO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    GoHealth Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - GoHealth, Inc. (0001808220) (Filer)

    8/19/25 4:20:38 PM ET
    $GOCO
    Specialty Insurers
    Finance

    Amendment: SEC Form SCHEDULE 13D/A filed by GoHealth Inc.

    SCHEDULE 13D/A - GoHealth, Inc. (0001808220) (Subject)

    8/13/25 5:28:06 PM ET
    $GOCO
    Specialty Insurers
    Finance

    SEC Form SCHEDULE 13D filed by GoHealth Inc.

    SCHEDULE 13D - GoHealth, Inc. (0001808220) (Subject)

    8/13/25 5:27:38 PM ET
    $GOCO
    Specialty Insurers
    Finance

    Credit Suisse resumed coverage on GoHealth with a new price target

    Credit Suisse resumed coverage of GoHealth with a rating of Underperform and set a new price target of $1.50

    4/1/22 7:10:27 AM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth downgraded by RBC Capital with a new price target

    RBC Capital downgraded GoHealth from Outperform to Sector Perform and set a new price target of $2.00 from $10.00 previously

    3/3/22 4:36:13 AM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth downgraded by Truist

    Truist downgraded GoHealth from Buy to Hold

    3/2/22 7:31:46 AM ET
    $GOCO
    Specialty Insurers
    Finance

    $GOCO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Public Sector Pension Investment Board claimed ownership of 1,680,526 shares (SEC Form 3)

    3 - GoHealth, Inc. (0001808220) (Issuer)

    8/15/25 10:03:07 AM ET
    $GOCO
    Specialty Insurers
    Finance

    Chief Executive Officer Kotte Vijay was granted 218,551 shares, increasing direct ownership by 19% to 1,347,396 units (SEC Form 4)

    4 - GoHealth, Inc. (0001808220) (Issuer)

    8/8/25 4:57:12 PM ET
    $GOCO
    Specialty Insurers
    Finance

    SEC Form 3 filed by new insider Carr Alan Jeffrey

    3 - GoHealth, Inc. (0001808220) (Issuer)

    8/8/25 2:44:30 PM ET
    $GOCO
    Specialty Insurers
    Finance

    $GOCO
    Financials

    Live finance-specific insights

    View All

    GoHealth Announces Strategic Capital and Governance Actions to Support Long-Term Value Creation and Reports Second Quarter 2025 Results

    CHICAGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO) ("GoHealth" or the "Company"), a leading health insurance marketplace and Medicare-focused digital health company, today announced the execution of strategic capital and governance actions that are expected to significantly enhance its financial flexibility and long-term positioning along with its financial results for the three and six months ended June 30, 2025. Strategic Capital and Governance Actions Secured new senior secured superpriority term loan facility, including $80.0 million in new-money term loans and $35.0 million in roll-up loans, to support working capital and stra

    8/7/25 7:00:00 AM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth to Announce Strategic Capital and Governance Actions to Support Long-Term Value Creation and Second Quarter 2025 Results

    CHICAGO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (GoHealth) (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, will announce strategic capital and governance actions to support long-term value creation and its second quarter 2025 financial results on the morning of August 7, 2025. Chief Executive Officer, Vijay Kotte, and Chief Financial Officer, Brendan Shanahan, will host a conference call and live audio webcast on the day of the release at 8:00 a.m. (ET) to discuss recent strategic capital and governance actions. A live audio webcast of the conference call will be available via GoHealth's Investor Relations websi

    8/6/25 4:15:00 PM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth Reports First Quarter 2025 Results

    CHICAGO, May 13, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO) ("GoHealth" or the "Company"), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three months ended March 31, 2025. First Quarter Highlights First quarter 2025 net revenues of $221.0 million, a 19.1% increase compared to $185.6 million in the prior year period.First quarter 2025 net loss of $9.8 million, a 54.2% improvement compared to a net loss of $21.3 million in the prior year period.First quarter 2025 Adjusted EBITDA1 of $42.1 million, a 56.4% increase compared to $26.9 million in the prior year period.First quarter 2025 Submissions2 were

    5/13/25 7:00:00 AM ET
    $GOCO
    Specialty Insurers
    Finance

    $GOCO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by GoHealth Inc. (Amendment)

    SC 13D/A - GoHealth, Inc. (0001808220) (Subject)

    8/25/23 6:15:20 AM ET
    $GOCO
    Specialty Insurers
    Finance

    SEC Form SC 13D/A filed by GoHealth Inc. (Amendment)

    SC 13D/A - GoHealth, Inc. (0001808220) (Subject)

    8/25/23 6:03:57 AM ET
    $GOCO
    Specialty Insurers
    Finance

    SEC Form SC 13D/A filed by GoHealth Inc. (Amendment)

    SC 13D/A - GoHealth, Inc. (0001808220) (Subject)

    5/19/23 6:08:49 AM ET
    $GOCO
    Specialty Insurers
    Finance

    $GOCO
    Leadership Updates

    Live Leadership Updates

    View All

    Brendan Shanahan Appointed Chief Financial Officer of GoHealth, Bringing Decades of Leadership in Healthcare and Financial Strategy

    CHICAGO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, today announced the appointment of Brendan Shanahan as Chief Financial Officer (CFO), effective October 14, following a comprehensive search process. Mr. Shanahan, a seasoned executive with over 30 years of financial leadership experience and over 20 years of expertise in the Medicare Advantage space, will oversee GoHealth's financial strategy and operations, contributing to the company's profitable growth and innovation efforts. "Brendan's extensive expertise in financial strategy, M&A, operational leadership, and deep knowledge of t

    10/10/24 9:00:00 AM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth Appoints Vance Johnston as Chief Financial Officer

    CHICAGO, Dec. 6, 2021 /PRNewswire/ -- GoHealth, Inc. (GoHealth) (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced today that Vance Johnston will join the Company as Chief Financial Officer (CFO) on December 7, 2021.  As previously announced, Travis Matthiesen, the Company's current CFO, will transition to the role of Chief Transformation Officer and will work closely with Johnston to ensure a smooth transition. "We are very pleased that Vance will be joining the GoHealth executive team as CFO," said Clint Jones, co-fou

    12/6/21 4:05:00 PM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth Appoints Dr. Paul Hain, M.D. as Chief Medical Officer

    CHICAGO, Dec. 1, 2020 /PRNewswire/ -- GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace, announced today that Dr. Paul Hain, M.D. has joined the company as Chief Medical Officer. In this newly created role, Dr. Hain will work side-by-side with GoHealth's growing TeleCare team, directly building clinical functions within the recently developed Encompass Platform, a digital health solution that provides strategic value to GoHealth members and enterprise partners. Dr. Hain will focus on key member touchpoints including care management and navigation, provider and value-based care engagement, pharmacy engagement, health risk assessments, social determinant of he

    12/1/20 8:06:00 AM ET
    $GOCO
    Specialty Insurers
    Finance